Material Safety Data Sheets (MSDSs) provide detailed information on the hazards associated with our products when handled in a workplace such as a pharmacy or a hospital. This information includes the product's potential health effects and physical hazards, its physical and chemical characteristics and recommendations for appropriate protective measures including spill cleanup, proper disposal and personal protective equipment.
To obtain an MSDS, select the name of the product from list below. If necessary, select the appropriate dosage form for that product.
ACTEMRA® (tocilizumab)
Activase® (Alteplase)
Anaprox® (naproxen sodium)
Boniva® (ibandronate sodium)
CellCept® (mycophenolate mofetil)
- CellCept (R) Oral Suspension
- CellCept (R) Powder for Oral Suspension
- CellCept(R) Lyophilized Vials (500 mg)
- CellCept(R) F.C. Tablets 500 mg
- CellCept(R) Capsules (Hard) 250 mg
Copegus® (ribavirin)
Cytovene® (ganciclovir)
Ec-Naprosyn® (naproxen)
Erivedge™ (vismodegib) Capsules
Fuzeon® (enfuvirtide)
Herceptin® (Trastuzumab)
Invirase® (saquinavir mesylate)
Klonopin® (clonazepam)
Kytril® (granisetron HCL)
Lucentis® (ranibizumab injection)
Naprosyn® (naproxen)
Nutropin® [somatropin (rDNA origin) for injection]
Nutropin AQ® [somatropin (rDNA origin) for injection]
Pegasys® (peginterferon alfa-2a)
- Pegasys (R) Vials (0.135 mg/mL)
- Pegasys (R) Vials (0.18 mg/mL)
- Pegasys (R) Prefilled Syringes (0.18mg / 0.5ml)
- Pegasys (R) Prefilled Syringes (0.135 mg / 0.5ml)
Rocephin® (ceftriaxone)
Romazicon (flumazenil)
- Romazicon (TM) Injection (10 ml vials)
- Romazicon (TM) Injection (5 ml vials)
- Romazicon (TM) Injection (3 ml vials)
Tamiflu® (oseltamivir phosphate)
- Tamiflu(R) Oral Suspension
- Tamiflu(R) Powder for Oral Suspension
- Tamiflu(R) Capsules (45 mg)
- Tamiflu(R) Capsules (30 mg)
- Tamiflu(R) Capsules (75 mg)
TNKase® (Tenecteplase)
Valcyte® (valganciclovir HCl)
Valium® (diazepam)
Xeloda® (capecitabine)
Xenical® (orlistat)
Xolair® (Omalizumab) for Subcutaneous Use
Zelboraf® (vemurafenib)
Zenapax® (daclizumab)